Perspective: Current Scientific Evidence and Research Strategies in the Role of Almonds in Cardiometabolic Health
Almonds are consumed by individuals around the world. Because almonds are rich in protein, unsaturated fatty acids, and fiber, a significant amount of research has been conducted on their role in affecting various cardiometabolic endpoints (body weight, blood pressure, blood cholesterol levels, and glycemic response). The most current meta-analyses on almond consumption and various health-related endpoints suggest that almond consumption does not result in weight gain and results in small reductions in LDL cholesterol and diastolic blood pressure, as well as improved glycemic responses in certain populations (i.e. Asian Indians). A number of research gaps on almond consumption and cardiometabolic health were identified that should be addressed to further understand their role in the various cardiometabolic endpoints, including the mechanisms of action interactions with the microbiome with regular consumption and their role as part of a healthy dietary pattern for both individuals and the general population.
Authors
- John L. Sievenpiper (ORCID: https://orcid.org/0000-0002-3270-5772)
- Anoop Misra (ORCID: https://orcid.org/0000-0001-5785-5833)
- France Bellisle (ORCID: https://orcid.org/0000-0002-6952-6890)
- Maha Tahiri
- Paula R. Trumbo (ORCID: https://orcid.org/0000-0003-4539-320X)
- Jack A. Gilbert (ORCID: https://orcid.org/0000-0001-7920-7001)
- Karol E. Watson (ORCID: https://orcid.org/0000-0003-3658-6165)
- Ronald L. Kleinman
- Jamy D. Ard (ORCID: https://orcid.org/0000-0002-1643-6795)
- James E. Hill
- Adam Drewnowski (ORCID: https://orcid.org/0000-0002-2892-9888)
Institutions
- St. Michael's Hospital (CA)
- Harvard University (US)
- Scripps Institution of Oceanography (US)
- University of California, Los Angeles (US)
- University of Toronto (CA)
- University of Washington (US)
- University of California System (US)
- University of Alabama at Birmingham (US)
- University of California San Diego (US)
- Massachusetts General Hospital (US)
- National Diabetes Obesity and Cholesterol Foundation (IN)
- Equipe de Recherche en Epidémiologie Nutritionnelle (FR)
- Wake Forest University (US)
- Liberty University (US)
Publication Details
- Journal
- Current Developments in Nutrition
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1016/j.cdnut.2024.104516
- Citations
- 2
- Primary Topic
- Nuts composition and effects
- Type
- article
- Field-Weighted Citation Impact
- 0.62
Funders
- U.S. Department of Agriculture
- Eli Lilly and Company
- GlaxoSmithKline
- Colgate-Palmolive Company
- PepsiCo
- General Mills
- UNICEF
- Danone
- Almond Board of California
- Regeneron Pharmaceuticals
- Dairy Farmers of Canada
- United Soybean Board
- Diabetes Canada
- Alberta Pulse Growers Commission
- Physicians Committee for Responsible Medicine
- UnitedHealth Group
- National Honey Board
- Institute for the Advancement of Food and Nutrition Sciences
- Government of Canada
- University of Toronto
- Novo Nordisk
- International Nut and Dried Fruit Council
- International Sweeteners Association
- FrieslandCampina
- Samsung
- Canadian Institutes of Health Research
- Ontario Ministry of Research and Innovation